Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection
Shuji Sumie(Kurume University), Michio Sata(Kurume University), Mina Komuta(Cliniques Universitaires Saint-Luc), Akio Takata(Kurume University), Ryoko Kuromatsu(Kurume University), Takumi Kawaguchi(Kurume University), Nobuyoshi Fukushima(Nagasaki Medical Center), Hironori Koga(Kurume University), Eiji Ando(Kurume University), Satoshi Itano(Kurume University Hospital), Koji Okuda(Kurume University), Eitaro Taniguchi(Kurume University), Masamichi Kojiro(Yanagawa Rehabilitation Hospital), Takuji Torimura(Omuta hospital)
Cited by 27
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504